id: https://openalex.org/W3004894342
doi: https://doi.org/10.1038/d41573-020-00016-0
title: Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
publication_date: '2020-02-10'
publication_year: 2020
cited_by_count: 1808
citation_percentile: 0.999579
pagerank: 3.1387267657384456e-06
authorships:
- author_id: https://openalex.org/A5074011681
  display_name: Guangdi Li
  orcid: https://orcid.org/0000-0001-8852-034X
  author_position: first
  institutions:
  - id: https://openalex.org/I139660479
    display_name: Central South University
    ror: https://ror.org/00f1zfq44
    country_code: CN
    type: funder
  is_corresponding: true
  raw_affiliation_strings:
  - Department of Epidemiology and Health Statistics, Xiangya School of Public Health,
    Central South University, Changsha, China.
- author_id: https://openalex.org/A5040662398
  display_name: Erik De Clercq
  orcid: https://orcid.org/0000-0002-2985-8890
  author_position: last
  institutions:
  - id: https://openalex.org/I24156275
    display_name: Rega Institute for Medical Research
    ror: https://ror.org/03w5j8p12
    country_code: BE
    type: facility
  - id: https://openalex.org/I99464096
    display_name: KU Leuven
    ror: https://ror.org/05f950310
    country_code: BE
    type: funder
  is_corresponding: true
  raw_affiliation_strings:
  - Department of Microbiology, Immunology and Transplantation, Rega Institute for
    Medical Research, KU Leuven, Leuven, Belgium.
referenced_works:
- https://openalex.org/W2255243349
- https://openalex.org/W2410066853
- https://openalex.org/W2965563959
- https://openalex.org/W3003465021
- https://openalex.org/W3005212621
- https://openalex.org/W3005527412
- https://openalex.org/W4250831696
primary_topic: SARS-CoV-2 and COVID-19 Research
open_access: true
